Listing 1 - 10 of 12 | << page >> |
Sort by
|
Choose an application
Pulmonary surfactant --- Surfactant pulmonaire --- Pulmonary surfactant.
Choose an application
This publication by the World Health Organization presents a target product profile for aerosolized surfactant therapy aimed at treating respiratory distress syndrome (RDS) in neonates, particularly in low- and middle-income countries. It outlines the development process of this profile, emphasizing the need for a safe, efficacious, and affordable surfactant that can be administered without intubation. The document discusses methods and technologies for delivering surfactant, highlighting recent advancements in aerosolization. The goal is to guide product developers and address the accessibility challenges of current surfactants in resource-limited settings. The intended audience includes healthcare professionals, policymakers, and product developers.
Choose an application
Fetus --- Lung --- Pulmonary alveoli --- Pulmonary surfactants --- Pulmonary surfactant. --- Metabolism. --- Growth and development. --- Enzymology. --- Biosynthesis.
Choose an application
Pathology of the respiratory system --- Physiology of the respiratory system --- Paediatrics --- Respiratory distress syndrome, Adult --- Respiratory distress syndrome --- Pulmonary surfactant --- Congresses --- Longen. Ventilatie / en oppervlaktespanning. (Congres) --- Maladie à membranes hyalines. (Congrès) --- Poumons. Ventilation / et tension superficielle. (Congrès) --- Hyalinemembranenziekte. (Congres) --- Respiratory distress syndrome, Adult - Congresses --- Respiratory distress syndrome - Congresses --- Pulmonary surfactant - Congresses
Choose an application
Surface active agents --- Solution (Chemistry) --- Solutions (Chimie) --- Congresses --- Congrès --- Pulmonary Surfactants. --- Solutions. --- Surface-Active Agents. --- 541.183 <063> --- -Surface active agents --- -Surfactants --- Chemistry, Organic --- Surface tension --- Wetting agents --- Pharmaceutical Solutions --- Pulmonary Surfactant --- Surfactant, Pulmonary --- Surfactants, Pulmonary --- Surface-Active Agents --- Contact systems. Adsorption. Surface chemistry--Congressen --- -Contact systems. Adsorption. Surface chemistry--Congressen --- 541.183 <063> Contact systems. Adsorption. Surface chemistry--Congressen --- -Pulmonary Surfactant --- Surfactants --- Congrès --- Pulmonary Surfactants --- Solutions --- Amphiphilic Agents --- Surface Active Agents --- Tensides --- Active Agents, Surface --- Agents, Amphiphilic --- Agents, Surface Active --- Agents, Surface-Active --- Lubricants --- Surface Active Agent --- Surface-Active Agent --- Surfactant --- Tenside --- Active Agent, Surface --- Agent, Surface Active --- Agent, Surface-Active --- Solution --- Viscosity. --- Chemical analysis
Choose an application
Pulmonary Surfactants. --- Solutions. --- Surface-Active Agents. --- 541.183 <063> --- Pharmaceutical Solutions --- Pulmonary Surfactant --- Surfactant, Pulmonary --- Surfactants, Pulmonary --- Surface-Active Agents --- Contact systems. Adsorption. Surface chemistry--Congressen --- 541.183 <063> Contact systems. Adsorption. Surface chemistry--Congressen --- Amphiphilic Agents --- Surface Active Agents --- Tensides --- Surfactants --- Active Agents, Surface --- Agents, Amphiphilic --- Agents, Surface Active --- Agents, Surface-Active --- Lubricants --- Surface Active Agent --- Surface-Active Agent --- Surfactant --- Tenside --- Active Agent, Surface --- Agent, Surface Active --- Agent, Surface-Active --- Solution --- Pulmonary Surfactants --- Solutions --- Surface (chemistry and physics)
Choose an application
Nanomedicine represents one of the most investigated areas in the last two decades in the field of pharmaceutics. Several nanovectors have been developed and a growing number of products have been approved. It is well known that many biomaterials are able to self-organize under controlled conditions giving rise nanostructures. Polymers, lipids, inorganic materials, peptides and proteins, and surfactants are examples of such biomaterials and the self-assembling property can be exploited to design nanovectors that are useful for drug delivery. The self-organization of nanostructures is an attractive approach to preparing nanovectors, avoiding complex and high-energy-consuming preparation methods, and, in some cases, facilitating drug loading procedures. Moreover, preparations based on these biocompatible and pharmaceutical grade biomaterials allow an easy transfer from the lab to the industrial scale. This book reports ten different works, and a review, aiming to cover multiple strategies and pharmaceutical applications in the field of self-organizing nanovectors for drug delivery.
chitosan --- encapsulation --- gold nanoparticles --- pH/redox-responsive --- bolaform amphiphilic lipids --- irradiation cycles --- drug delivery --- caries prevention --- bolalipids --- nanocage --- natural extracts --- astaxanthin --- eukaryotic vaults --- nanoparticles --- amphiphilic random copolymers --- zoledronic acid --- triggered release --- nanohydrogels --- doxorubicin --- vapor nanobubbles --- curcumin --- gold reduction --- diffusion barrier --- liposomes --- hyaluronan --- laser treatment --- nanoparticle --- mixed polymeric micelles --- protein self-assembly --- squalene --- antimicrobial photodynamic therapy --- self-assembly --- hydrogel --- C-peptide --- polyelectrolyte complexes --- siRNA delivery --- drug delivery system --- biofilms --- pulmonary surfactant --- multidrug resistance --- drug delivery systems --- nano-assemblies --- photo-thermal therapy --- anticancer --- polypeptides --- graphene quantum dots --- nanovesicles --- aerogel --- resveratrol --- intracellular therapy --- Oral antimicrobials --- syringeable implant --- trehalose --- betulinic acid --- in situ gelling systems --- autophagy induction --- chorioallantoic membrane model --- controlled release --- diabetes --- oxidative stress --- localized heating effect
Choose an application
When is clinical research in developing countries exploitation? Exploitation is a concept in ordinary moral thought that has not often been analyzed outside the Marxist tradition. Yet it is commonly used to describe interactions that seem morally suspect in some way. A case in point is clinical research sponsored by developed countries and carried out in developing countries, with participants who are poor and sick, and lack education. Such individuals seem vulnerable to abuse. But does this, by itself, make such research exploitative? Exploitation and Developing Countries is an attempt by philosophers and bioethicists to reflect on the meaning of exploitation, to ask whether and when clinical research in developing countries counts as exploitative, and to consider what can be done to minimize the possibility of exploitation in such circumstances. These reflections should interest clinical researchers, since locating the line between appropriate and inappropriate use of subjects--the line between exploitation and fair use--is the central question at the heart of research ethics. Reflection on this rich and important moral concept should also interest normative moral philosophers of a non-Marxist bent. In addition to the editors, the contributors are Richard J. Arneson, Alisa L. Carse, Margaret Olivia Little, Thomas Pogge, Andrew W. Siegel, and Alan Wertheimer.
Clinical trials --- Moral and ethical aspects --- Controlled clinical trials --- Patient trials of new treatments --- Randomized clinical trials --- Trials, Clinical --- Études cliniques --- Pulmonary Surfactants. --- Human Experimentation --- Hepatitis A Vaccines. --- Developing Countries. --- Clinical Trials as Topic --- Developing Nations --- Least Developed Countries --- Less-Developed Nations --- Third-World Nations --- Under-Developed Nations --- Less-Developed Countries --- Third-World Countries --- Under-Developed Countries --- Countries, Developing --- Countries, Least Developed --- Countries, Less-Developed --- Countries, Third-World --- Countries, Under-Developed --- Country, Developing --- Country, Least Developed --- Country, Less-Developed --- Country, Third-World --- Country, Under-Developed --- Developed Countries, Least --- Developed Country, Least --- Developing Country --- Developing Nation --- Least Developed Country --- Less Developed Countries --- Less Developed Nations --- Less-Developed Country --- Less-Developed Nation --- Nation, Less-Developed --- Nation, Third-World --- Nation, Under-Developed --- Nations, Developing --- Nations, Less-Developed --- Nations, Third-World --- Nations, Under-Developed --- Third World Countries --- Third World Nations --- Third-World Country --- Third-World Nation --- Under Developed Countries --- Under Developed Nations --- Under-Developed Country --- Under-Developed Nation --- Havrix --- Hepatitis A Vaccine --- Hepatovirus Vaccines --- Vaqta --- Vaccine, Hepatitis A --- Vaccines, Hepatitis A --- Vaccines, Hepatovirus --- Pulmonary Surfactant --- Surfactant, Pulmonary --- Surfactants, Pulmonary --- Surface-Active Agents --- Clinical medicine --- Human experimentation in medicine --- Aspect social --- ethics. --- Research --- Developing Countries --- Hepatitis A Vaccines --- Pulmonary Surfactants --- Études cliniques --- ethics --- Clinical trials - Moral and ethical aspects - Developing countries --- Clinical Trials as Topic - ethics --- Human Experimentation - ethics --- Études cliniques - Aspect social - Pays en voie de développement
Choose an application
Membranes play an enormous role in our life. Biological cell membranes control the fluxes of substances in and out of cells. Artificial membranes are widely used in numerous applications including “green” separation processes in chemistry, agroindustry, biology, medicine; they are used as well in energy generation from renewable sources. They largely mimic the structure and functions of biological membranes. The similarity in the structure leads to the similarity in the properties and the approaches to study the laws governing the behavior of both biological and artificial membranes. In this book, some physico-chemical and chemico-physical aspects of the structure and behavior of biological and artificial membranes are investigated.
Technology: general issues --- ion exchange membranes --- profiled membranes --- corrugated membranes --- electrodialysis --- reverse electrodialysis --- membrane capacitive deionization --- hydrodynamic --- mass transfer --- thermal pressing --- 3D printing --- acid whey --- pulsed electric field --- demineralization --- scaling --- lactic acid removal --- ion exchange membrane --- profiled membrane --- CFD --- pressure drop --- structural mechanics --- fluid-structure interaction --- whey --- pulsed electrodialysis reversal --- fouling --- electrodialysis with filtration membrane (EDFM) --- triple size-selective separation --- glucose uptake --- bioassay-guided validation --- bioactive peptides --- electro-convective instability --- overlimiting current --- concentration polarisation --- particle tracking --- biomimetic membrane --- ion pair amphiphile --- cholesterol --- molecular dynamics --- water permeation --- air-pollutant nanoparticle --- coarse-grained model --- interaction --- molecular dynamics simulation --- pulmonary surfactant monolayer --- PP membrane --- O2 plasma --- TiO2 nanoparticles --- UV treatment --- hydrophilicity --- biopolymer electrolyte membranes --- XRD analysis --- FTIR study --- Morphology --- Impedance study --- EDLC fabrication --- LaPO4: Ce --- Tb --- ionic liquid --- supported liquid membrane --- photoluminescence --- hyperbranched polymer --- crosslinking --- alkaline fuel cells --- ionic conductivity --- water swelling --- ion-exchange membranes --- ion-exchange particles --- heterogeneity --- electrokinetics --- current-voltage curves --- ion-exchange membrane --- Fujifilm --- Neosepta --- phosphate transport --- limiting current density --- voltammetry --- zinc-air battery --- separator --- hydroxide exchange membrane --- anion-exchange membrane --- ionic channel --- polyphenylene oxide --- polymer inclusion membrane --- ionic liquids --- volatile fatty acids (VFAs) --- acetic acids --- hexanoic acids --- anomalous water diffusion --- computer simulations --- ion channel gating --- nano-size water pore --- physico-chemical properties of confined water --- protein-water interactions --- TRPV1 channel permeability for water --- water dynamics --- water H-bonding --- NETs --- inner nuclear membrane --- outer nuclear membrane --- nuclear envelope --- polymer blends --- impedance study --- dielectric properties --- electric modulus study --- loss tangent peaks --- ion transport parameters --- Trukhan model --- salinity gradient power --- concentration difference --- electrolyte composition
Choose an application
Proteomics --- Proteins --- Biochemistry --- Proteome. --- Protéines --- Biochimie --- Biochemistry. --- Proteomics. --- Research --- genetics. --- Recherche --- Research. --- Protein research --- Biological chemistry --- Chemical composition of organisms --- Organisms --- Physiological chemistry --- Proteomes --- Proteids --- Composition --- Protéines --- Molecular biology --- Biology --- Chemistry --- Medical sciences --- Biomolecules --- Polypeptides --- Health Sciences --- Physiology --- Proteome --- proteome. --- proteins. --- genetics --- Biological Sciences --- animal genetics --- cytogenetics --- gender --- genetic equilibrium --- genetic factors --- genetic relationships --- genetic selection --- genetic stability --- genetic structure --- genetic traits --- genetic vectors --- genomics --- human genetics --- immunogenetics --- inheritance (genetics) --- landscape genetics --- maternal effect --- metabolomics --- microbial genetics --- molecular genetics --- nutrigenomics --- paternal effect --- phenomics --- phenotype --- plant genetics --- population genetics --- proteomics --- quantitative genetics --- reproductive fitness --- sex determination --- transcriptomics --- biotechnology --- breeding --- genetic models --- genetic resources --- geneticists --- amino acids, peptides and proteins --- advanced glycation end products --- advanced oxidation protein products --- agglutinins --- algal proteins --- angiogenic proteins --- animal proteins --- antifreeze proteins --- antimicrobial proteins --- apoproteins --- binding proteins --- BTB-Kelch proteins --- chloroplast proteins --- conjugated proteins --- contractile proteins --- CRISPR-associated proteins --- crystal proteins --- crystallins --- cytoskeletal proteins --- gelatin --- GTPase-activating proteins --- helminth proteins --- heme proteins --- insecticidal proteins --- kinesin --- lectins --- luminescent proteins --- membrane proteins --- microbial proteins --- mitochondrial proteins --- molecular chaperones --- molecular motor proteins --- multiprotein complexes --- neoplasm proteins --- nuclear-encoded proteins --- nuclear proteins --- nucleoproteins --- peptones --- phosphoproteins --- phytohemagglutinin --- plant proteins --- polyproteins --- prions --- protein aggregates --- protein corona --- protein products --- protozoan proteins --- pulmonary surfactant associated proteins --- receptors --- recombinant proteins --- regulatory proteins --- ribonucleoproteins --- ribosomal proteins --- scaffolding proteins --- scleroproteins --- selenoproteins --- seminal plasma proteins --- silver proteins --- simple proteins --- storage proteins --- structural proteins --- sulfur proteins --- surface proteins --- thermostable proteins --- transcobalamins --- transcription factors --- tubulin --- ubiquitins --- viral proteins --- protein sweeteners --- proteinuria --- proteolytic bacteria --- proteome --- phosphoproteome --- metabolome --- proteins --- sialome --- biochemistry --- molecular biology --- proteomics --- protein science --- systems biology --- bioinformatics --- Protéomique --- Protéomes.
Listing 1 - 10 of 12 | << page >> |
Sort by
|